Pharm--Hypertension
Terms
undefined, object
copy deck
- Primary HTN
-
-90% of cases
-aka Essential HTN
-Not due to identifiable causes
-can't be cured - Secondary HTN
-
-10%
-due to another identifiable cause - Goals of HTN Therapy
-
-Reduce morbidity/mortality
-Prevent CCD and TOD
modify other cardiovasc. risk factors - What are the BP goals?
-
general <140/90
Diabetic, CRI <130/80 - Non-Pharm Therapies
-
weight reduction
salt restriction
smoking cessation
alcohol restriction (1 oz. for males and .5 oz. for females)
exercise (30-45 min, 3-4xweek
adequate intake of K, Mg, Ca
low fat, low cholesterol diet - NL BP classification
- SBP <120 and DBP <80
- Tx for NL BP
- encourage lifestyle modification, no HTN meds
- Pre-HTN classification
- SBP 120-139 or DBP 80-89
- Tx for Pre-HTN
- lifestyle modification, no HTN meds
- Stage I HTN classification
- SBP 140-159 or DBP 90-99
- Tx for Stage I HTN
- lifestyle modification, Thiazide diuretic for most, consider ACE, ARB, BB, CCB
- Stage II HTN classification
- SBP >160 or DBP >100
- Tx for Stage II HTN
- lifestyle modification, 2 drug combo with thiazide diuretic for most, plus ACE, ARB, BB, CCB
- What are compelling indications for HTN? Tx for any classification with compelling indications
-
CRI or DM
diuretics, ACE, ARB, BB, CCB as needed - If pt. is not at goal BP and has had no response or troublesome side effects, what is the next step
- substitute another drug from a different class
- If pt. is not at goal BP and has had inadequate response, but tolerated the drugs well, what is the next step
- add a 2nd agent for different class (diuretic is not already used)
- If either of these pt. are still not at goal BP, what is the next step
-
continue optimizing dosages or adding agents from other classes until BP is achieved
or may need to refer to a HTN specialist - when is Tx initiated with 2 drugs
- BP >20/10mmHg above the goal
- Uncomplicated HTN
- thiazide diuretic for most pt., except ACE-I in white males (ALLHAT trial)
- Tx in the elderly
-
-more sensitive than younger pt.
-req. lower intial and maintenance doses
-more gradual and longer intervals btwn dose adjustments or addition
-presence of orthostasis
-impaired renal and hepatic fxn
-decr. beta-adrenergic fxn - What is the principle Tx in Caucasians and why?
- BB and ACE-I because high-renin system
- What is the principle Tx in AA pt. and why
- diuretics and CCB because low-renin system
- T/F Pre-menopausal women are at same risk for HTN as males
- False--they are at lower risk because the presence of endogenous estrogen has a protective risk, but post-menopausal women are at equal risk compared to men
- Estimates of Compliance
-
-daily or 2x a day
-combination products to simplify regimes
-avoid agents with potential for rebound HTN (clonidine) - which is the most cost-effective anti-HTN drug
- diuretic
- Diuretics initial MOA
- initially decr. plasma volume (SV), which will decr. CO and thus decr. BP
- Diuretics MOA after continued use
- decr. peripheral vascular resistance, thereby decr. BP
- What are the 3 types of diuretics
- Thiazide, loop, and potassium sparing
- Thiazide efficacy
-
-AA > whites
-very effective in elderly
-synergy with ACE, ARB, BB
-useful in pt. w/ uncomplicated HTN, ISH, osteoporosis (retains Ca) - Thiazide Adverse Reactions
-
Electrolyte disturbance
Hyperuricemia
hyperglycemia
photosensitivity
impotence, dehydration, dizziness, nausea, polyuria - Loop efficacy
-
-weak anti-HTN
-maybe useful in pt. with renal insufficiency
-useful in pt. with CHF - Loop adverse effects
- similar side effects as Thiazide, except decr. Ca and lipid and glucose abn. not as severe
- Potassium Sparing Efficacy
-
-often not effective for HTN
-used in combo with thiazide to decr. incidence of hypokalemia - What drugs are the exception to the rule of not using K sparing and when?
-
-spironolactone--used in severe CHF
-Eplerenone--used in severe CHF and post-MI - K sparing adverse effects
-
incr. K
spironolactone--gynecomastia - What side effect do all diuretics potentially have
-
increase Scr and BUN
may cause gout attack - Diuretic drug interactions
-
-ACE-I: precipitous fall in BP, renal insufficiency
-K sparing diuretics + ACE/ARB: increases risk of hyperkalemia - Beta Blockers MOA
-
-decr. HR and CO
-block renin release and decrease plasma volume - Beta Blockers Efficacy
-
-young > elderly
-good in combo w/ diuretic (the alpha-blocker)
-smoking may decr. efficacy
-useful in pt. w/ concomitant A-tachy, AFib, angina, migraine, throtoxicosis, peri-operative HTN, s/p MI, benign essential tremor, CHF - BB precautions/Side effects
-
-bronchospasm in pt. w/ asthma or COPD
-Bradycardia, AV block
-fatigue, decr. exercise tolerance, depression
-incr. TG, decr. HDL
-hyperglycemia
-erectile dysfunction - In diabetics, what are the precautions/side effects for using BB
-
-blunts natural response to hypoglycemia
-masks symptoms of hypoglycemia - What peripheral vascular precautions/side effects exist for BB
-
-acts at the B2 receptors of arterioles causing vasoconstriction
-this can:
may worsen Raynaud's dz
may worsen intermittent claudication - BB drug interactions w/ decongestants
- antagonize the effects of BB; can raise BP
- BB drug interactions w/ Verapamil/dilitazem
- risk of significant bradycardia, AV block
- BB drug interactions w/ NSAIDs and COX-2 inhibitors
- blunt antihypertensive effects
- BB drug interactions w/ thyroid hormones
- antagonistic effect
- BB drug interactions w/ Digoxin/Digitoxin
- incr. risk for bradycardia
- what can abrupt discontinuation of BB cause
-
-rebound HTN
in pt. w/ CAD, may produce unstable angina, MI , or even death
-need to taper over 14 days - BB Contraindications
-
-asthma, COPD
-avoid labetalol in liver dz
-2nd/3rd degree heart block
-sick sinus syndrome
-? PVD
-do not start in pt. with acute heart failue - alpha-1, beta blockers
- similar to other BB, but also has alpha-blockade which produces more orthostasis
- Example of alpha-1, beta blockers
-
-Labetalol--inidicated in pregnancy
-Carvedilol--indicated in heart failure - alpha-1 blockers
-
-reduces vasc. resistance from sympathetic activation--decr. PVR
-vasodilation--induces smooth msc. relaxation, no reflex tachy - alpha-1 blockers efficacy
-
-improves lipid profile
-useful in pt. w/ BPH, hyperlipidemia
-tolerance may occur over time - alpha-1 blockers precautions/side effects
-
-1st dose syncope, orthostasis (esp. in elderly)
-h/a
-dizziness - alpha-1 blockers dosing compliance
- start low and titrate slowly to avoid orthostasis
- alpha-1 blocker drugs
-
Doxazosin
Terazosin
Prazosin - alpha-1 blockers pt. education
-
-take at bedtime in supine position
-avoid driving for 12-24 hrs. after any change in meds
-change positions slowly - ACE-I/ARB efficacy
-
-less effective as monotherapy in AA
-good in combo
-effective in mild-severe HTN
-lipid neutral
-beneficial effects on glucose/insulin sensitivity
-useful in CHF, DM, s/p MI< high coronary dz risk, renal insufficiency - ACE-I/ARB precautions/side effects
-
-cough (less w/ ARB)
-renal--incr. Scr, BUN, hyperkalemia
-CI in bilat. renal a. stenosis
-angioedema
-hypotension
-metallic taste
-fetal death (CI in pregnancy) - ACE-I/ARB drug interactions
-
-ACE-I: precip. fall in BP
-NSAIDs/ASA/COX-2: inhibit anti-HTN effects of ACE-I
-K sparing drugs: incr. risk of hyperkalemia
-lithium: incr. risk for toxicity - Calcium Channel Blockers
-
-decreases PVR
-different effects on HR, contractility, AV-nodal contraction - 2 types of CCB
-
1. nondihydropyridine
2. dihydropyridine - non-dihydropyridine drugs
- verapamil and diltiazem
- dihydropyridine (DHP) drugs
-
amlodipine
felodipine
isradipine
nifedipine
nisoldipine - CCB efficacy
-
-AA > whites
-mild-severe HTN
-DHP--useful in ISH, angina
-non-DHP--useful in diastolic dysfxn, migraine, angina, a-tachy, Afib, DM w/ proteinuria - CCB contraindications
- systolic heart failure or heart block: verapamil and diltiazem
- Central Adrenergic Inhibitors MOA
-
-stim. central postsynaptic alpha-2 receptors in the brain
-decr. sympathetic activity to periphery, decr. plasma NE, decr. PVR
-suppress plasma renin activity - Central Adrenergic Inhibitors drugs
-
clonidine
methyldopa
guanfacine
guanabenz - Central Adrenergic Inhibitors Efficacy
-
-very potent, not 1st line Tx
-use w/ diuretic sec. to Na/fluid retention
-best not to use w. preipheral alpha-1 blockers - Clonidine
- rapid onset,good for HTN urgency
- Methyldopa
- drug of choice in pregnancy
- Central Adrenergic Inhibitors Precautions/Side Effects
- withdrawal syndrome (rebound HTN)
- Central Adrenergic Inhibitors Drug Interactions
- abrupt discontinuation of clonidine can cause life-threatening HTN crisis
- Direct Vasodilators
-
-decr. PVR (afterload)
-reflex tachycardia
-Na and water retention
-direct smooth msc. relaxation and dilation of arterioles - Direct Vasodilators drugs
-
Hydralazine
Minoxidil - Direct Vasodilators Efficacy
-
-decr. DBP > SBP
-not as monotherapy, not 1st line
-very useful in resistant HTN - Hydralazine
- good for pt. w/ systolic HF
- Minoxidil
-
-more potent than hydralazine
-useful for pt. w/ renal insufficiency who are refractory to all other Tx - Direct Vasodilators precautions/side effects
-
-lupus-like syndrome
-hypotension
-reflex tachycardia (need BB)
-edema (need diuretic) - Minoxidil side effects
-
-hair growth
-precipitate angina in pt. w/ CAD - Useful drug combinations
-
BB + diuretic
ACE + diuretic
ARB + diuretic
CCB + ACE - Pre-clampsia
-
-presents after 20wks.
-HTN >140/90 w/ proteinuria, hyperuricemia, coag abn.
-can be fatal for mother and fetus - Tx for pre-clampsia
-
-delivery, bed rest, activity restriction
-IV hydralazine or IV labetalol
-Nifedipine IR oral has been used, but not FDA approved - HTN urgency
-
-benefit from reducing BP w/in 24-48 hrs.
-DBP >120mmHg w/ min. to no TOD, usually asymptomatic
-not life-threatening - TX for HTN urgency
-
-Avoid nifedipine and other CCB (short-acting)
-use fast acting drug ORAL agents
-Captopril
-Clonidine
-Labetalol
-Prazosin - HTN emergency
-
-DBP >120 mmHg and symptomatic
-life-threatening - Drug-induced caused of HTN emergency
-
-MAO-I and tyramine interactions
-overdose w/ phenyclidine, cocaine, LSD (ilicit drugs) - Tx goals
-
-immediate BP reduction to a safe value to prevent/limit TOD and death
- decr. MAP by 20-25% w/in 2 hrs., then goal of 160/100mmHg
-avoid rapid reduction in BP bc can cause ischemic damage - Tx for HTN emergency
-
IV route:
-Na nitroprusside
-Nicardipine
-Labetalol
-Fenoldopam
-Nitroglycerine (acute MI)
-Hydralazine (pregnancy)
-Diazoxide (obsolete)